Video Back Videos home Signature collection Essentials collection Artificial Intelligence Trending searches ...

Net interest income was 14% higher YoY, at ₹587.7 crore, due to steady loan growth & higher interest margins than Q3 FY24 levels of ₹516 crore.

Vaccines. Two vaccines against MUC1 are in Phase III trials. The BLP25 liposome vaccine (L-BLP25, also known as stimuvax) (Oncothyreon, Merck KGaA, EMD Serono) is a liposome-based vaccine designed ...

The second day of the 9th "International Symposium on Current Trends in Drug Discovery Research” at CSIR-Central Drug Research Institute, Lucknow, observed important scientific deliberations by ...

a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr ...

BACKGROUND: Circular RNAs derived from both nuclear and mitochondrial genomes are identified in animal cells.